NovoRapid injection 100 units/mL, by Novo Nordisk Pharma, contains Insulin aspart (recombinant) and is a rapid-acting insulin used to manage blood sugar levels in patients with diabetes mellitus. It has a YJ code of 2492415A3031 and a standard of 300 units per tube, and can also be used for continuous subcutaneous insulin infusion in pump systems.
NovoRapid injection 100 units/mL
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).